Role of APLP2 in the prognosis and clinicopathology of renal cell carcinoma

  • Authors:
    • Lijian Gao
    • Hongda Zhao
    • Dongqing Zhang
    • Changkuo Zhou
    • Hui Wang
    • Chantao Ren
    • Yaxiao Liu
    • Yangyang Xia
    • Benkang Shi
  • View Affiliations

  • Published online on: October 15, 2018     https://doi.org/10.3892/ol.2018.9577
  • Pages: 508-513
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Identifying diagnostic and prognostic biomarkers is crucial for improved guidance of the treatment of renal cell carcinoma (RCC). Amyloid β precursor‑like protein 2 (APLP2) has been determined to serve an important role in the progression of a number of cancer types. However, the expression and significance of APLP2 in RCC remains unknown. In the present study, it was determined that the expression of APLP2 protein (n=10) and mRNA (n=8) expression was significantly decreased in clear cell RCC (CCRCC) tissues compared with that in matched normal renal tissues. The expression level of APLP2 was significantly associated with high Fuhrman grade, high pT stage, and presence of distant metastasis and lymph node metastasis (P<0.05). Multivariate analysis demonstrated that the expression of APLP2 was a significant independent predictor of disease‑specific survival in renal cell carcinoma (P=0.026). Notably, APLP2 expression was significantly associated with disease‑specific survival (P<0.001). APLP2 may be used to potentially predict patient prognosis, and to guide clinical diagnosis and treatment in CCRCC.
View Figures
View References

Related Articles

Journal Cover

January-2019
Volume 17 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gao L, Zhao H, Zhang D, Zhou C, Wang H, Ren C, Liu Y, Xia Y and Shi B: Role of APLP2 in the prognosis and clinicopathology of renal cell carcinoma. Oncol Lett 17: 508-513, 2019
APA
Gao, L., Zhao, H., Zhang, D., Zhou, C., Wang, H., Ren, C. ... Shi, B. (2019). Role of APLP2 in the prognosis and clinicopathology of renal cell carcinoma. Oncology Letters, 17, 508-513. https://doi.org/10.3892/ol.2018.9577
MLA
Gao, L., Zhao, H., Zhang, D., Zhou, C., Wang, H., Ren, C., Liu, Y., Xia, Y., Shi, B."Role of APLP2 in the prognosis and clinicopathology of renal cell carcinoma". Oncology Letters 17.1 (2019): 508-513.
Chicago
Gao, L., Zhao, H., Zhang, D., Zhou, C., Wang, H., Ren, C., Liu, Y., Xia, Y., Shi, B."Role of APLP2 in the prognosis and clinicopathology of renal cell carcinoma". Oncology Letters 17, no. 1 (2019): 508-513. https://doi.org/10.3892/ol.2018.9577